Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Advance reports: Hokusai-VTE trial – edoxaban equal efficacy and better safety compared to warfarin

bs_subtitle

Hokusai-VTE trial: edoxaban equal efficacy and better safety compared to warfarin In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin (LMWH), according to the results of the Hokusai-VTE trial. VTE is the collective term for potentially fatal blood clots in the legs, deep vein thrombosis (DVT) and in the lungs, pulmonary embolism (PE). The results from the global phase 3 Hokusai-VTE study of 8,292 patients with either acute symptomatic DVT, PE, or both were presented recently

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy